Sources | Names Used |
---|---|
CTRPv2 | sirolimus:bortezomib (250:1 mol/mol) |
PharmacoGx | sirolimus:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AC023283.1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | AC096949.1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | ACAA2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | ACADM | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | ACADS | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | ACCS | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
mRNA | ACO2 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | ACOT7 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | ACR | CTRPv2 | pan-cancer | AAC | -0.091 | 0.005 |
mRNA | ACSF3 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |